Gait Evaluation in Haemophiliac Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00824798

Acronym

GAIT_GENERAL

Enrollment

Registered

2009-01-19

Start date

2009-01-31

Completion date

2011-01-31

Last updated

2019-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemophilia A, Hemophilia B

Keywords

gait, haemophilia, arthropathy

Brief summary

Joint damage secondary to recurrent haemarthroses and chronic synovitis represents the commonest clinical manifestation of haemophilia. Incapacitating pain, loss of joint stability and mobility, axial deviation, deterioration and decreased function are the most frequent complains in patients with severe haemophilic arthropathy In this context, the purpose of our study is to examine and analyse specific changes in gait in patients suffering from haemophilic arthropathy and determine the impact on health-related quality of life in terms of conceptual components of pain and stiffness, psychosocial stress, disability, and activity limitations as recommended by the International Classification of Function (ICF) recently published by the World Health Organization.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

5 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* haemophilia A or B * aged more than 4 years

Exclusion criteria

* impossibility to walk on a treadmill * recent joint haemarthrosis or muscle haematoma

Design outcomes

Primary

Measure	Time frame
evaluate specific changes in gait in patients suffering from haemophilic arthropathy	from inclusion in the study until 1 year after inclusion

Countries

Belgium

Outcome results